Seer, Inc. (SEER)
NASDAQ: SEER · IEX Real-Time Price · USD
2.110
-0.010 (-0.47%)
May 17, 2024, 4:00 PM EDT - Market closed
Seer, Inc. Revenue
Seer, Inc. had revenue of $15.67M in the twelve months ending March 31, 2024, down -3.45% year-over-year. Revenue in the quarter ending March 31, 2024 was $3.07M, a -24.35% decrease year-over-year. In the year 2023, Seer, Inc. had annual revenue of $16.66M with 7.54% growth.
Revenue (ttm)
$15.67M
Revenue Growth
-3.45%
P/S Ratio
8.64
Revenue / Employee
$106,626
Employees
147
Market Cap
135.39M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 16.66M | 1.17M | 7.54% |
Dec 31, 2022 | 15.49M | 8.88M | 134.14% |
Dec 31, 2021 | 6.62M | 5.96M | 908.69% |
Dec 31, 2020 | 656.00K | 540.00K | 465.52% |
Dec 31, 2019 | 116.00K | - | - |
Dec 31, 2018 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
TruBridge | 336.45M |
American Well | 254.57M |
Karyopharm Therapeutics | 140.46M |
InfuSystem Holdings | 127.41M |
Seres Therapeutics | 126.85M |
Akoya Biosciences | 93.57M |
OptiNose | 74.02M |
I-Mab | 3.90M |
SEER News
- 9 days ago - Seer Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 9 days ago - Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions - GlobeNewsWire
- 24 days ago - Seer to Report First Quarter 2024 Financial Results on May 8, 2024 - GlobeNewsWire
- 2 months ago - Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook - GlobeNewsWire
- 3 months ago - Seer to Participate in the TD Cowen 44th Annual Health Care Conference - GlobeNewsWire
- 3 months ago - Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery - GlobeNewsWire
- 3 months ago - Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024 - GlobeNewsWire
- 5 months ago - Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference - GlobeNewsWire